Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571259 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antimicrobial Catheter Lock
A Phase 4 study, sponsored by Satellite Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 303
- Enrollment target
NCT00571259 is a Phase 4 study that has completed, run by Satellite Healthcare. The registered enrollment target is 303 participants.
The verdict
NCT00571259, a Phase 4 study, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 303 participants
- Enrollment target
Study Summary
This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.
Interventions
- DRUG Heparin 1000U/mL
- DRUG 4% Sodium Citrate with Gentamicin 320 mcg/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2003-09 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00571259
The ClinicalTrials.gov registry entry for NCT00571259 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 303 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Satellite Healthcare, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Heparin 1000U/mL is the first listed.
NCT00571259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00571259 about?
NCT00571259 is a clinical study titled "Prophylactic Antimicrobial Catheter Lock". This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.
What is the current status of trial NCT00571259?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 303 participants. The study started on 2003-09. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00571259?
The interventions under investigation include: Heparin 1000U/mL (DRUG), 4% Sodium Citrate with Gentamicin 320 mcg/mL (DRUG).
Who is sponsoring clinical trial NCT00571259?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.